Related Experiment Videos
Natural Alkaloids Against Liver Injury: Mechanistic Insights and Multi-Target Therapeutic Potential
Yating Xiao1, Zhirui Tian1, Jie Cui1
1Key Laboratory of Protection, Development and Utilization of Medicinal Resources in Liupanshan Area, Ministry of Education, School of Pharmacy, Ningxia Medical University, No. 1160 Shengli Street, Yinchuan 750004, China.
Abstract:
Liver injury is a complex pathological condition with increasing incidence due to diverse etiologies, including drug-induced liver injury, metabolic dysfunction-associated steatotic liver disease, alcoholic liver disease, viral hepatitis, and autoimmune disorders. Its progression is characterized by persistent hepatic damage and gradual loss of liver function, which may ultimately lead to fibrosis, cirrhosis, and liver failure. However, currently available hepatoprotective drugs still present several limitations, such as insufficient target specificity, limited therapeutic efficacy, and potential adverse effects, highlighting the need for safer and more effective alternatives. Based on a comprehensive search of databases including PubMed, Web of Science, China National Knowledge Infrastructure and Google Scholar, this review summarizes the pathogenic mechanisms of major liver injury types and the therapeutic potential of natural alkaloids. As key secondary metabolites of medicinal plants, alkaloids exhibit structural diversity, potent bioactivities, and favorable safety profiles. Increasing evidence suggests that natural alkaloids exert hepatoprotective effects through multi-target and multi-pathway mechanisms, including the regulation of oxidative stress, inflammation, lipid metabolism, and cell death. These findings highlight their promising potential for the prevention and treatment of liver injury and provide a theoretical basis for the development of novel hepatoprotective agents.
Related Concept Videos
Antidotes
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Principles of Drug Action
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Drug Toxicity: Dose-Dependent Reactions
Pharmaceutical Poisoning: Treatment Strategies